Overview
Patient safety is the top priority all players in the pharmaceutical and medical devices industry. As part of their mission, many companies in the sector commit to providing access to safe medicines. The WHO estimates that up to 8% of medical devices and up to 30% of medicines on the market are fakes. During our first webinar, experts agreed it is a growing problem, and serialisation on its own is not the solution.
• What happens when a medicine/device is a fake – even though it carries your brand name?
• How can you stop fake drugs from getting into your patients’ hands?
• How can you make field inspections efficient, so that you can take fast countermeasures?
• How can you take advantage of your drug being delivered in a plastic medical device?
Join SICPA, Clariant and Kroll for the second of a two-part webinar series. In this webinar, focusing on PLASTIWARD®, you will learn:
• Why fast authentication in the field offered by PLASTIWARD®, is a key element in your brand security measures and protecting the patient.
• What advantages the PLASTIWARD® real-time monitoring platform offers during an investigation process.
• How PLASTIWARD® can be included in the protection of your medical device/packaging: close to the drug and low impact on design, regulatory, production.
Learning Objectives:
- How the PLASTIWARD® system offers the advantage of real-time authentication and complements your serialisation activity.
- Investigation process: What are some of the issues and how does PLASTIWARD® help?
- Practical advice on how to implement PLASTIWARD® into your medical device /packaging.
Speakers:
Steve Duckworth
Head of Global Segment Medical & Pharma, BU Masterbatches, Clariant Plastics & Coatings
Steve Duckworth is a graduate in Applied Chemistry with over 30 years spent in the polymers and compounding industries in R&D, marketing and operations functions. He also works as an independent consultant for market analysis, M&A, and Asia entry strategies. He joined Clariant in 2007. Since January 2011 he is the head of the segment focused on Healthcare, leading a team of dedicated specialists based in USA, Europe and Asia. Steve is vice-chairman and executive board member of the cross industry group MedPharmPlast Europe, and member of the regulatory affairs committee of this association.
Yann Ischi
Director New Channels and Partnerships Product and Brand Protection, SICPA SA
Yann Ischi, Director New Channels & Partnership at SICPA SA, helps private-sector clients improve their supply chain security and enhance brand protection. He works with companies who share our mission and whose expertise complements ours.
Yann previously headed SICPA’s Design & Product Management team and provided security architecture expertise. He worked with public sector officials and developed and implemented robust security solutions for passports, identity papers and other value documents.
Yann holds a Bachelor of Science and an Executive MBA in entrepreneurship and innovation.
Kroll Inc
Kroll’s Business and Cyber Investigations team is specialized in digital investigations, including open source, and the tools and methodologies that enable clients to combat cybercrime, leaks of confidential information, counterfeiting, and intellectual property (IP) theft.
Medical Plastics News
The voice of the medical plastics industry
Medical Plastics News is the voice of the medical plastics industry. It is an essential source of business critical, highly relevant and unique intelligence, which stimulates thought leadership and nurtures an innovative and connected community of industry stakeholders.
Register Now!
Already registered for this webinar?
Just enter the email address you used to register.
First time here?
Please fill in the registration form below.
